News
Medical device tax helps push Spectranetics further into the red in Q1
April 24, 2013 12:49 pm | by Mass Device | CommentsColorado-based medical device maker Spectranetics (NSDQ:SPNC) broke out the red ink in 2013, blaming the swing partly on the newly implemented medtech excise tax, which requires that companies pay a 2.3% levy on all U.S. sales of applicable medical devices.
NeuroMetrix to Partner with Omron Healthcare for Distribution of NC-stat DPNCheck in Japan
April 24, 2013 11:32 am | by The Associated Press | CommentsWALTHAM, Mass.--(BUSINESS WIRE)--Apr 24, 2013--NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the treatment of diabetic peripheral neuropathy (DPN), announced that it had entered into an agreement with Omron Healthcare Co., Ltd. to be the exclusive distributor for NC-stat ®...
Texas Institute for Robotic Surgery Among First in Nation To Perform Single-Site Robotic Hysterectomy Surgery
April 24, 2013 10:53 am | by PR Newswire | CommentsAUSTIN, Texas, April 24, 2013 /PRNewswire/ -- The Texas Institute for Robotic Surgery at St. David's North Austin Medical Center recently became one of the first facilities in the nation to perform a hysterectomy using a new single-site platform for robotic surgery.
Z-Medica Announces Expanded CE Indications for QuikClot Hemostatic Dressings Supporting Broader Use in Surgical Wound Care
April 24, 2013 10:07 am | by PR Newswire | CommentsWALLINGFORD, Conn., April 24, 2013 /PRNewswire/ -- Z-Medica®, a leading developer and marketer of hemostatic agents, announced newly expanded CE indications for QuikClot® Hemostatic Dressings today. The expanded indications support the use of QuikClot® products as an...
Sensor System to Assess the Effects of Explosions on Soldiers
April 24, 2013 9:59 am | by T.J. Becker, Georgia Tech | CommentsImprovised explosive devices (IEDs) are becoming a global problem for the U.S. armed forces. To prevent injuries to soldiers and provide better care to those who are injured, the U.S. military is striving to better understand how blasts impact the human body.
A Non-Invasive Breath Test for Lung Cancer
April 24, 2013 9:18 am | by Dr. John Cormier, Picomole | CommentsPicomole has announced that it has developed a diagnostic test to detect lung cancer that has a preliminary accuracy of 98.5%. This best-in-class result is better than any other technique currently in use for the detection of lung cancer, according to the company.
Treatment Adherence Emerging as Critical Theme in Improving Quality and Cost of US Healthcare
April 24, 2013 6:21 am | by PR Newswire | CommentsAs leaders across business, policy and academia gathered at the recent World Health Care Congress (WHCC) to discuss ways to improve the quality and cost of healthcare, experts in treatment adherence identified a common theme: a patient-centric adherence strategy will be critical to achieving success.
Consumer Information on: DePuy Ceramax Ceramic Total Hip System - P070026S004
April 24, 2013 12:00 am | by U.S. Food & Drug Administration | CommentsThis is a brief overview of information related to FDA’s approval to market this product. See the links to the Summary of Safety and Effectiveness Data (SSED) and product labeling for more complete information on this product, its indications for use, and the basis for FDA’s approval.
Questions over Gene Patents Shake Diagnostics Industry
April 24, 2013 12:00 am | by Massachusetts Institute of Technology | CommentsAt this week’s Biotechnology Industry Organization show in Chicago, a panel of law experts bemoaned the recent Supreme Court hearings on whether individual genes can be patented, saying there was no sign that anyone involved in the case truly understood the technology or the business implications of their arguments.
Millstone Medical Outsourcing Expands Medical Device Distribution Services
April 23, 2013 6:05 pm | by PR Newswire | CommentsMillstone Medical Outsourcing announced today that the company will offer customers an expanded medical device distribution service, which includes the ability to distribute directly to patients and to provide wholesale distribution to distributors, hospitals, and sales representatives.
Hundreds of Tiny Untethered Surgical Tools in First Animal Biopsies
April 23, 2013 4:36 pm | by Phil Sneiderman, Johns Hopkins University | CommentsBy using swarms of untethered grippers, each as small as a speck of dust, Johns Hopkins engineers and physicians say they have devised a new way to perform biopsies that could provide a more effective way to access narrow conduits in the body as well as find early signs of cancer or other diseases.
Reports: Obamacare architect Baucus to step down at year's end
April 23, 2013 2:34 pm | by Mass Device | CommentsSen. Max Baucus (D-Mont.) is reportedly planning to retire when his current term ends this year, according to multiple news outlets today, potentially removing a key opponent to the medical device industry's push to repeal a 2.3% tax on U.S. medtech sales.
Obese Men With Benign Biopsy at High Risk for Prostate Cancer
April 23, 2013 1:00 pm | by AACR | CommentsObese men were more likely to have precancerous lesions detected in their benign prostate biopsies compared with nonobese men and were at a greater risk for subsequently developing prostate cancer, according to data published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
Interrad Medical Announces Excellent SecurAcath Clinical Study Results in Two New Publications Which Highlight Patient and Cost-Effectiveness Benefits
April 23, 2013 12:56 pm | by The Associated Press | CommentsInterrad Medical, Inc. a privately held medical device company, announced today the publication of clinical study data for the SecurAcath catheter securement device in the Journal of Infusion Nursing, May/June 2013 issue and the Canadian Journal of Anesthesia May 2013 issue.
Mauna Kea Technologies Announces Highlights of 5th Annual International Conference of Cellvizio(R) Users (ICCU)
April 23, 2013 11:45 am | by The Associated Press | CommentsMauna Kea Technologies (NYSE Euronext: MKEA), leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, today announced highlights from the 5th Annual International Conference of Cellvizio Users (ICCU) held in Versailles, France, from April 5 to 7. Over 200...
